Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Bioequivalence: Overview01:16

Bioequivalence: Overview

975
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
975
Case Studies01:22

Case Studies

11.6K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.6K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overwhelming Post-Splenectomy Sepsis From Capnocytophaga canimorsus.

International journal of laboratory hematology·2026
Same author

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

The Lancet. Haematology·2026
Same author

Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report.

Case reports in medicine·2026
Same author

Generics in science communication: Misaligned interpretations across laypeople, scientists, and large language models.

Public understanding of science (Bristol, England)·2026
Same author

Clinical outcomes in triple-negative myeloproliferative neoplasms with extreme thrombocytosis: a case series.

Leukemia & lymphoma·2026
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Coming to America: Bioethical Training at the Kennedy Institute of Ethics and the Establishment of Medical Ethics in Germany.

Kennedy Institute of Ethics journal·2026
Same journal

A Reply to Bernstein, Jayaram, and Hutler's "Assessing the Liberty-Based Case Against Pandemic Lockdowns".

Kennedy Institute of Ethics journal·2026
Same journal

Assessing the Liberty-Based Case Against Pandemic Lockdowns.

Kennedy Institute of Ethics journal·2026
Same journal

Relational Autonomy in Nonideal Medical Decision-Making.

Kennedy Institute of Ethics journal·2026
Same journal

Ambiguous Invitations: Nonmaleficence, Uncertainty Attitudes and Public Health Policy.

Kennedy Institute of Ethics journal·2026
Same journal

Editor's Note, June 2025.

Kennedy Institute of Ethics journal·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

Generalizations in Clinical Trials-Do Generics Help Or Harm?

Benjamin Chin-Yee

    Kennedy Institute of Ethics Journal
    |July 8, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Medical research generalizations, often used as generics, risk misinterpretation. To avoid communication "slippage," avoid generic claims in public medical contexts and use them cautiously in private physician-patient interactions.

    More Related Videos

    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.4K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K

    Related Experiment Videos

    Last Updated: Jun 21, 2025

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    00:04

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    10.6K
    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.4K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K

    Area of Science:

    • Philosophy of Science
    • Medical Ethics
    • Linguistics

    Background:

    • Generalizations in medical research are common but can be misleading.
    • Generics, a type of generalization lacking quantifiers, are prevalent in clinical trials.
    • Existing research highlights attention to generics from various disciplines.

    Purpose of the Study:

    • To analyze common generalizations in clinical trials as natural language generics.
    • To diagnose the function and malfunction of medical generics across contexts.
    • To propose new norms for public science communication.

    Main Methods:

    • Analysis of generalizations in clinical trials as generics.
    • Application of probabilistic and contextual features of generics.
    • Examination of communicative contexts in medicine.

    Main Results:

    • Generic generalizations in medicine carry a high risk of misinterpretation or "slippage."
    • Generics function and malfunction differently across various communicative contexts.
    • Vigilance is required when using generics, especially in public and private medical settings.

    Conclusions:

    • Avoid generic claims about medical interventions in public contexts like clinical trials.
    • Use generics with caution and vigilance in private contexts, such as physician-patient encounters.
    • The analysis provides tools for vigilance and raises ethical questions in clinical communication.